Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.50 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.50 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.50 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.44 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.44 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11093962 | 0.89 | LMNA (0.60) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL10976239 | 0.88 | CYP1A2 (0.60) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL6760088 | 0.86 | CYP1A2 (0.62) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL9803023 | 0.85 | LMNA (0.58) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL22847567 | 0.83 | LMNA (0.60) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL28409004 | 0.81 | LMNA (0.59) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL16574245 | 0.80 | LMNA (0.69) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL13650209 | 0.80 | LMNA (0.50) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 | |
| SCHEMBL4118603 | 0.79 | MAPK1 (0.57) | — | |
| SCHEMBL28820753 | 0.79 | LMNA (0.71) | LMNACYP1A2SMN1; SMN2KDM4EGRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9551724-B2 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL, INC. (US) | 2017-01-24 | — | — | US | disclosed |
| US-20100204456-A1 | 5-Fluoro-Uracil Immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2010-08-12 | — | — | US | disclosed |
| US-7767794-B2 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL INC (US) | 2010-08-03 | — | — | US | disclosed |
| US-20070154972-A1 | 5-Fluoro-uracil immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2007-07-05 | — | — | US | disclosed |
| US-7205116-B2 | 5-Fluoro-uracil immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2007-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204456-A1 | 5-Fluoro-Uracil Immunoassay | UNG, DPYD, DUT | LMNA 4568/4885CYP1A2 3994/4885SMN1; SMN2 3493/4885 |
| US-20070154972-A1 | 5-Fluoro-uracil immunoassay | UNG, DPYD, DUT | LMNA 4568/4885CYP1A2 3994/4885SMN1; SMN2 3493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.